General
Dengue vaccine more risky for people without prior infection – Sanofi
 

Dengue vaccine more risky for people without prior infection – Sanofi

Shared by:

 
Philippine Health Secretary Francisco Duque III says the 'safety of Filipino children' is the prime consideration as health officials meet on the implications of Sanofi Pasteur's advisory on Dengvaxia
 
www.rappler.com
 
30 Nov 2017 - General
 
There is an update from the pharmaceutical company that their product is most effective when the patient has been previously infected with the dengue virus and it is not recommended to those who don't have a prior infection. Let me quote their explanation, "The analysis confirmed that Dengvaxia provides persistent protective benefit against dengue fever in those who had prior infection. For those not previously infected by dengue virus, however, the analysis found that in the longer ter...
 (Total 92 words)